extract from an article on Seeking Alpha
For the pediatric trial, however, there is really nothing left to discuss. The trial was a failure. How much of an effect the pediatric Rett data will have on the rest of the pipeline is anyone's guess, but for now, the stock has taken a terrible beating, going down losing 40% overnight.The company did try to explain the poor show by claiming a very strong placebo effect, but their reasons sounded hollow.
- Forums
- ASX - By Stock
- ANAVEX MEETS ENDPOINTS PHASE2 RETT
extract from an article on Seeking Alpha For the pediatric...
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.09 |
Change
-0.220(1.14%) |
Mkt cap ! $2.437B |
Open | High | Low | Value | Volume |
$19.14 | $19.14 | $18.50 | $7.048M | 371.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 420 | $19.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.09 | 1 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 630 | 18.950 |
1 | 27 | 18.900 |
1 | 132 | 18.850 |
1 | 170 | 18.810 |
1 | 50 | 18.710 |
Price($) | Vol. | No. |
---|---|---|
19.110 | 225 | 1 |
19.200 | 20 | 1 |
19.240 | 1000 | 1 |
19.490 | 2000 | 1 |
19.500 | 1000 | 1 |
Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
Last
$19.03 |
  |
Change
-0.220 ( 0.79 %) |
|||
Open | High | Low | Volume | ||
$18.96 | $19.10 | $18.52 | 96070 | ||
Last updated 15.59pm 10/05/2024 ? |
Featured News
NEU (ASX) Chart |